Founders Thoughts on Emerging Reimbursement Pathways
Momentum is building across the UK and Europe toward evidence-based reimbursement for MedTech. With NICE and HTA bodies taking a more central role, innovators should align early with evaluation criteria to unlock emerging national and local funding pathways.
Like what you read?
Sign up for updates and be the first to know when we post.